2023-12-012024-11-302024-11-30false14492869KENT ORAL FACIAL SURGERY LTD2025-01-1986220falseiso4217:GBPxbrli:pure144928692023-12-01144928692024-11-30144928692023-12-012024-11-30144928692022-11-18144928692023-11-30144928692022-11-182023-11-3014492869bus:SmallEntities2023-12-012024-11-3014492869bus:AuditExempt-NoAccountantsReport2023-12-012024-11-3014492869bus:FullAccounts2023-12-012024-11-3014492869bus:PrivateLimitedCompanyLtd2023-12-012024-11-3014492869core:WithinOneYear2024-11-3014492869core:AfterOneYear2024-11-3014492869core:WithinOneYear2023-11-3014492869core:AfterOneYear2023-11-3014492869core:ShareCapital2024-11-3014492869core:SharePremium2024-11-3014492869core:RevaluationReserve2024-11-3014492869core:OtherReservesSubtotal2024-11-3014492869core:RetainedEarningsAccumulatedLosses2024-11-3014492869core:ShareCapital2023-11-3014492869core:SharePremium2023-11-3014492869core:RevaluationReserve2023-11-3014492869core:OtherReservesSubtotal2023-11-3014492869core:RetainedEarningsAccumulatedLosses2023-11-3014492869core:LandBuildings2024-11-3014492869core:PlantMachinery2024-11-3014492869core:Vehicles2024-11-3014492869core:FurnitureFittings2024-11-3014492869core:OfficeEquipment2024-11-3014492869core:NetGoodwill2024-11-3014492869core:IntangibleAssetsOtherThanGoodwill2024-11-3014492869core:ListedExchangeTraded2024-11-3014492869core:UnlistedNon-exchangeTraded2024-11-3014492869core:LandBuildings2023-11-3014492869core:PlantMachinery2023-11-3014492869core:Vehicles2023-11-3014492869core:FurnitureFittings2023-11-3014492869core:OfficeEquipment2023-11-3014492869core:NetGoodwill2023-11-3014492869core:IntangibleAssetsOtherThanGoodwill2023-11-3014492869core:ListedExchangeTraded2023-11-3014492869core:UnlistedNon-exchangeTraded2023-11-3014492869core:LandBuildings2023-12-012024-11-3014492869core:PlantMachinery2023-12-012024-11-3014492869core:Vehicles2023-12-012024-11-3014492869core:FurnitureFittings2023-12-012024-11-3014492869core:OfficeEquipment2023-12-012024-11-3014492869core:NetGoodwill2023-12-012024-11-3014492869core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3014492869core:ListedExchangeTraded2023-12-012024-11-3014492869core:UnlistedNon-exchangeTraded2023-12-012024-11-3014492869core:MoreThanFiveYears2023-12-012024-11-3014492869core:Non-currentFinancialInstruments2024-11-3014492869core:Non-currentFinancialInstruments2023-11-3014492869dpl:CostSales2023-12-012024-11-3014492869dpl:DistributionCosts2023-12-012024-11-3014492869core:LandBuildings2023-12-012024-11-3014492869core:PlantMachinery2023-12-012024-11-3014492869core:Vehicles2023-12-012024-11-3014492869core:FurnitureFittings2023-12-012024-11-3014492869core:OfficeEquipment2023-12-012024-11-3014492869dpl:AdministrativeExpenses2023-12-012024-11-3014492869core:NetGoodwill2023-12-012024-11-3014492869core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3014492869dpl:GroupUndertakings2023-12-012024-11-3014492869dpl:ParticipatingInterests2023-12-012024-11-3014492869dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-012024-11-3014492869core:ListedExchangeTraded2023-12-012024-11-3014492869dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-012024-11-3014492869core:UnlistedNon-exchangeTraded2023-12-012024-11-3014492869dpl:CostSales2022-11-182023-11-3014492869dpl:DistributionCosts2022-11-182023-11-3014492869core:LandBuildings2022-11-182023-11-3014492869core:PlantMachinery2022-11-182023-11-3014492869core:Vehicles2022-11-182023-11-3014492869core:FurnitureFittings2022-11-182023-11-3014492869core:OfficeEquipment2022-11-182023-11-3014492869dpl:AdministrativeExpenses2022-11-182023-11-3014492869core:NetGoodwill2022-11-182023-11-3014492869core:IntangibleAssetsOtherThanGoodwill2022-11-182023-11-3014492869dpl:GroupUndertakings2022-11-182023-11-3014492869dpl:ParticipatingInterests2022-11-182023-11-3014492869dpl:GroupUndertakingscore:ListedExchangeTraded2022-11-182023-11-3014492869core:ListedExchangeTraded2022-11-182023-11-3014492869dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-11-182023-11-3014492869core:UnlistedNon-exchangeTraded2022-11-182023-11-3014492869core:NetGoodwill2024-11-3014492869core:IntangibleAssetsOtherThanGoodwill2024-11-3014492869core:LandBuildings2024-11-3014492869core:PlantMachinery2024-11-3014492869core:Vehicles2024-11-3014492869core:FurnitureFittings2024-11-3014492869core:OfficeEquipment2024-11-3014492869core:AfterOneYear2024-11-3014492869core:WithinOneYear2024-11-3014492869core:ListedExchangeTraded2024-11-3014492869core:UnlistedNon-exchangeTraded2024-11-3014492869core:ShareCapital2024-11-3014492869core:SharePremium2024-11-3014492869core:RevaluationReserve2024-11-3014492869core:OtherReservesSubtotal2024-11-3014492869core:RetainedEarningsAccumulatedLosses2024-11-3014492869core:NetGoodwill2023-11-3014492869core:IntangibleAssetsOtherThanGoodwill2023-11-3014492869core:LandBuildings2023-11-3014492869core:PlantMachinery2023-11-3014492869core:Vehicles2023-11-3014492869core:FurnitureFittings2023-11-3014492869core:OfficeEquipment2023-11-3014492869core:AfterOneYear2023-11-3014492869core:WithinOneYear2023-11-3014492869core:ListedExchangeTraded2023-11-3014492869core:UnlistedNon-exchangeTraded2023-11-3014492869core:ShareCapital2023-11-3014492869core:SharePremium2023-11-3014492869core:RevaluationReserve2023-11-3014492869core:OtherReservesSubtotal2023-11-3014492869core:RetainedEarningsAccumulatedLosses2023-11-3014492869core:NetGoodwill2022-11-1814492869core:IntangibleAssetsOtherThanGoodwill2022-11-1814492869core:LandBuildings2022-11-1814492869core:PlantMachinery2022-11-1814492869core:Vehicles2022-11-1814492869core:FurnitureFittings2022-11-1814492869core:OfficeEquipment2022-11-1814492869core:AfterOneYear2022-11-1814492869core:WithinOneYear2022-11-1814492869core:ListedExchangeTraded2022-11-1814492869core:UnlistedNon-exchangeTraded2022-11-1814492869core:ShareCapital2022-11-1814492869core:SharePremium2022-11-1814492869core:RevaluationReserve2022-11-1814492869core:OtherReservesSubtotal2022-11-1814492869core:RetainedEarningsAccumulatedLosses2022-11-1814492869core:AfterOneYear2023-12-012024-11-3014492869core:WithinOneYear2023-12-012024-11-3014492869core:Non-currentFinancialInstrumentscore:CostValuation2023-12-012024-11-3014492869core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-012024-11-3014492869core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-012024-11-3014492869core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-012024-11-3014492869core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-012024-11-3014492869core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-012024-11-3014492869core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3014492869core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3014492869core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3014492869core:Non-currentFinancialInstrumentscore:CostValuation2024-11-3014492869core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-3014492869core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-3014492869core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-3014492869core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-3014492869core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-3014492869core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-3014492869core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-3014492869core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-3014492869core:Non-currentFinancialInstrumentscore:CostValuation2023-11-3014492869core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-3014492869core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-3014492869core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-3014492869core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-3014492869core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-3014492869core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-3014492869core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-3014492869core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-3014492869bus:Director12023-12-012024-11-30

KENT ORAL FACIAL SURGERY LTD

Registered Number
14492869
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2024

KENT ORAL FACIAL SURGERY LTD
Company Information
for the year from 1 December 2023 to 30 November 2024

Director

BOYAPATI, Raghuram Prasad

Registered Address

270 Canterbury Road
Kennington
Ashford
TN24 9QN

Registered Number

14492869 (England and Wales)
KENT ORAL FACIAL SURGERY LTD
Balance Sheet as at
30 November 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets77,334-
77,334-
Current assets
Cash at bank and on hand3,82225,413
3,82225,413
Creditors amounts falling due within one year3(25,710)(15,836)
Net current assets (liabilities)(21,888)9,577
Total assets less current liabilities55,4469,577
Net assets55,4469,577
Capital and reserves
Called up share capital11
Profit and loss account55,4459,576
Shareholders' funds55,4469,577
The financial statements were approved and authorised for issue by the Director on 19 January 2025, and are signed on its behalf by:
BOYAPATI, Raghuram Prasad
Director
Registered Company No. 14492869
KENT ORAL FACIAL SURGERY LTD
Notes to the Financial Statements
for the year ended 30 November 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
2.Average number of employees

20242023
Average number of employees during the year11
3.Creditors: amounts due within one year

2024

2023

££
Amounts owed to related parties25,36013,590
Taxation and social security-2,246
Accrued liabilities and deferred income350-
Total25,71015,836